Related Experiment Videos
Mutational and structural analysis of the binding interface between type I interferons and their receptor Ifnar2
1Department of Biological Chemistry, Weizmann Institute of Science, Rehovot, 76100, Israel.
Journal of Molecular Biology
|November 11, 1999
Summary
Type I interferons (IFN) signal by binding to cell receptors. This study identifies key binding sites on IFNalpha2 and its receptor ifnar2, revealing how mutations affect antiviral activity and signaling.
Area of Science:
- Immunology
- Biophysics
- Molecular Biology
Background:
- Type I interferons (IFN) mediate crucial immune responses by binding to cell surface receptors ifnar1 and ifnar2.
- Understanding the biophysical basis of IFN-receptor interactions is vital for elucidating IFN signaling pathways.
Purpose of the Study:
- To characterize the functional epitopes and biophysical interactions between IFNalpha2 and the extracellular domain of ifnar2 (ifnar2-EC).
- To investigate the impact of specific mutations on binding affinity, thermodynamic parameters, and antiviral potency.
Main Methods:
- Utilized a mutational study on purified recombinant IFNalpha2 and ifnar2-EC proteins.
- Employed label-free heterogeneous phase detection to determine kinetic and thermodynamic parameters.
- Correlated anti-viral potency of mutants with binding affinity to ifnar2.
Main Results:
- Identified a small functional epitope on IFNalpha2, with residues L30 and R33 as critical hot-spots contributing significantly to interaction energy.
- Localized hot-spot residues (T46, I47, M48) and other key residues on ifnar2 involved in IFNalpha2 binding.
- Established a proportional correlation between binding affinity and anti-viral potency, suggesting receptor binding is rate-limiting for IFN signaling.
- Revealed distinct binding centers for IFNalpha2 and IFNbeta on ifnar2, despite competitive binding, potentially influencing signaling orientation.
Conclusions:
- Detailed mapping of functional epitopes on IFNalpha2 and ifnar2 provides insights into the molecular basis of Type I IFN signaling.
- The identified hot-spot residues are crucial for high-affinity binding and subsequent antiviral activity.
- Differential binding modes of IFNalpha2 and IFNbeta suggest a mechanism for distinct signaling outcomes.